| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Four-Dimensional Computed Tomography | 24 | 2023 | 226 | 5.170 |
Why?
|
| Positron-Emission Tomography | 46 | 2024 | 2173 | 4.180 |
Why?
|
| Tomography, X-Ray Computed | 64 | 2024 | 7551 | 4.170 |
Why?
|
| Positron Emission Tomography Computed Tomography | 13 | 2024 | 833 | 3.890 |
Why?
|
| Phantoms, Imaging | 49 | 2023 | 1271 | 3.760 |
Why?
|
| Respiration | 27 | 2024 | 447 | 3.520 |
Why?
|
| Image Processing, Computer-Assisted | 38 | 2023 | 1648 | 3.320 |
Why?
|
| Artifacts | 34 | 2020 | 532 | 3.210 |
Why?
|
| Movement | 25 | 2018 | 556 | 2.810 |
Why?
|
| Respiratory-Gated Imaging Techniques | 7 | 2022 | 51 | 2.680 |
Why?
|
| Cone-Beam Computed Tomography | 13 | 2023 | 202 | 2.590 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 21 | 2021 | 361 | 2.420 |
Why?
|
| Imaging, Three-Dimensional | 18 | 2014 | 925 | 2.030 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 16 | 2023 | 2370 | 1.770 |
Why?
|
| Respiratory Mechanics | 12 | 2020 | 173 | 1.670 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 13 | 2020 | 305 | 1.650 |
Why?
|
| Motion | 16 | 2023 | 193 | 1.600 |
Why?
|
| Algorithms | 32 | 2023 | 3890 | 1.530 |
Why?
|
| Lung Neoplasms | 34 | 2023 | 11538 | 1.460 |
Why?
|
| Radiographic Image Enhancement | 12 | 2019 | 402 | 1.330 |
Why?
|
| Image Interpretation, Computer-Assisted | 11 | 2015 | 592 | 1.200 |
Why?
|
| Fluorodeoxyglucose F18 | 12 | 2022 | 1226 | 1.090 |
Why?
|
| Image Enhancement | 9 | 2019 | 561 | 0.920 |
Why?
|
| Reproducibility of Results | 28 | 2020 | 6009 | 0.850 |
Why?
|
| Heart | 17 | 2020 | 1223 | 0.830 |
Why?
|
| Tomography, Spiral Computed | 6 | 2010 | 133 | 0.760 |
Why?
|
| Sodium Fluoride | 2 | 2020 | 30 | 0.750 |
Why?
|
| Subtraction Technique | 9 | 2007 | 141 | 0.730 |
Why?
|
| Radiosurgery | 4 | 2017 | 1330 | 0.720 |
Why?
|
| Artificial Intelligence | 3 | 2021 | 388 | 0.710 |
Why?
|
| Fluorine Radioisotopes | 3 | 2019 | 133 | 0.710 |
Why?
|
| Radiation Dosage | 11 | 2022 | 1014 | 0.710 |
Why?
|
| Radiography, Thoracic | 11 | 2015 | 462 | 0.700 |
Why?
|
| Lung | 8 | 2023 | 3151 | 0.690 |
Why?
|
| Multimodal Imaging | 5 | 2023 | 550 | 0.690 |
Why?
|
| Calcinosis | 2 | 2020 | 423 | 0.680 |
Why?
|
| Esophageal Neoplasms | 8 | 2017 | 3168 | 0.670 |
Why?
|
| Computer Simulation | 15 | 2024 | 1529 | 0.670 |
Why?
|
| Whole Body Imaging | 1 | 2019 | 114 | 0.650 |
Why?
|
| Inventions | 1 | 2018 | 37 | 0.620 |
Why?
|
| Arteries | 1 | 2019 | 274 | 0.610 |
Why?
|
| Stroke Volume | 2 | 2020 | 577 | 0.600 |
Why?
|
| Heart Rate | 1 | 2020 | 737 | 0.570 |
Why?
|
| Liver Neoplasms | 7 | 2020 | 4557 | 0.520 |
Why?
|
| Humans | 114 | 2024 | 261506 | 0.520 |
Why?
|
| Pacemaker, Artificial | 1 | 2018 | 213 | 0.520 |
Why?
|
| Defibrillators, Implantable | 1 | 2018 | 221 | 0.510 |
Why?
|
| Radiopharmaceuticals | 9 | 2018 | 1301 | 0.490 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2021 | 88 | 0.480 |
Why?
|
| Thorax | 7 | 2022 | 213 | 0.460 |
Why?
|
| Sensitivity and Specificity | 17 | 2015 | 4971 | 0.460 |
Why?
|
| Equipment Design | 7 | 2019 | 1204 | 0.450 |
Why?
|
| Exhalation | 3 | 2024 | 60 | 0.450 |
Why?
|
| Time Factors | 15 | 2020 | 12926 | 0.420 |
Why?
|
| Radiotherapy, Image-Guided | 2 | 2013 | 304 | 0.400 |
Why?
|
| Models, Theoretical | 8 | 2019 | 785 | 0.380 |
Why?
|
| Radiotherapy, Conformal | 3 | 2013 | 902 | 0.380 |
Why?
|
| Models, Statistical | 8 | 2015 | 1171 | 0.370 |
Why?
|
| Tumor Burden | 6 | 2017 | 1987 | 0.370 |
Why?
|
| Diagnostic Imaging | 2 | 2018 | 1162 | 0.370 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 9 | 2018 | 5319 | 0.370 |
Why?
|
| Thoracic Neoplasms | 4 | 2007 | 337 | 0.360 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2010 | 53 | 0.360 |
Why?
|
| Radiotherapy Dosage | 5 | 2020 | 3842 | 0.330 |
Why?
|
| Prostate-Specific Antigen | 2 | 2023 | 993 | 0.320 |
Why?
|
| Radiotherapy | 2 | 2012 | 1824 | 0.300 |
Why?
|
| Myocardium | 4 | 2020 | 1313 | 0.290 |
Why?
|
| Radiation Oncology | 2 | 2008 | 529 | 0.290 |
Why?
|
| Neoplasms | 4 | 2019 | 15193 | 0.280 |
Why?
|
| Automation | 5 | 2013 | 151 | 0.280 |
Why?
|
| Feasibility Studies | 7 | 2017 | 2292 | 0.270 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2006 | 123 | 0.250 |
Why?
|
| Retrospective Studies | 14 | 2023 | 37905 | 0.250 |
Why?
|
| Radionuclide Imaging | 2 | 2023 | 660 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 7702 | 0.220 |
Why?
|
| Brain Stem | 1 | 2023 | 175 | 0.220 |
Why?
|
| Signal-To-Noise Ratio | 2 | 2019 | 117 | 0.220 |
Why?
|
| Quality Assurance, Health Care | 1 | 2007 | 585 | 0.210 |
Why?
|
| Radiation Pneumonitis | 2 | 2018 | 301 | 0.200 |
Why?
|
| Organ Motion | 1 | 2020 | 4 | 0.200 |
Why?
|
| Atherosclerosis | 2 | 2020 | 935 | 0.190 |
Why?
|
| Emphysema | 1 | 2022 | 87 | 0.190 |
Why?
|
| Aged | 21 | 2020 | 70117 | 0.190 |
Why?
|
| Male | 30 | 2023 | 123000 | 0.190 |
Why?
|
| Gallium Radioisotopes | 1 | 2020 | 60 | 0.190 |
Why?
|
| Cyclobutanes | 1 | 2020 | 36 | 0.190 |
Why?
|
| Pulmonary Emphysema | 1 | 2022 | 145 | 0.190 |
Why?
|
| Carboxylic Acids | 1 | 2020 | 57 | 0.190 |
Why?
|
| Radiation Exposure | 1 | 2020 | 73 | 0.180 |
Why?
|
| Organometallic Compounds | 1 | 2020 | 191 | 0.180 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 29902 | 0.170 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2019 | 54 | 0.170 |
Why?
|
| Contrast Media | 5 | 2019 | 1472 | 0.170 |
Why?
|
| Reference Standards | 1 | 2019 | 339 | 0.160 |
Why?
|
| Biological Transport | 1 | 2019 | 597 | 0.150 |
Why?
|
| Rotation | 3 | 2014 | 112 | 0.150 |
Why?
|
| Data Mining | 1 | 2018 | 88 | 0.150 |
Why?
|
| Risk | 2 | 2020 | 1972 | 0.150 |
Why?
|
| Triiodobenzoic Acids | 2 | 2008 | 68 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 306 | 0.140 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 1997 | 121 | 0.140 |
Why?
|
| Female | 23 | 2019 | 141928 | 0.140 |
Why?
|
| Middle Aged | 21 | 2020 | 86204 | 0.140 |
Why?
|
| Data Interpretation, Statistical | 2 | 2008 | 482 | 0.130 |
Why?
|
| Prostatectomy | 1 | 2020 | 962 | 0.130 |
Why?
|
| Fourier Analysis | 1 | 2015 | 94 | 0.130 |
Why?
|
| Tomography, Emission-Computed | 3 | 2006 | 310 | 0.130 |
Why?
|
| Scattering, Radiation | 3 | 2010 | 316 | 0.130 |
Why?
|
| Prostatic Neoplasms | 2 | 2023 | 5767 | 0.130 |
Why?
|
| Heart Ventricles | 1 | 2020 | 846 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 3578 | 0.120 |
Why?
|
| Cardiology | 1 | 2020 | 530 | 0.120 |
Why?
|
| Coronary Angiography | 2 | 2011 | 598 | 0.120 |
Why?
|
| Lymphoma | 1 | 2022 | 1467 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2020 | 2203 | 0.110 |
Why?
|
| Pyridazines | 1 | 2015 | 293 | 0.110 |
Why?
|
| Calcium | 1 | 2019 | 1537 | 0.110 |
Why?
|
| Particle Accelerators | 2 | 2014 | 352 | 0.110 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 799 | 0.110 |
Why?
|
| Organ Size | 1 | 2013 | 690 | 0.100 |
Why?
|
| Patient Safety | 1 | 2018 | 649 | 0.100 |
Why?
|
| Video Recording | 1 | 2013 | 267 | 0.100 |
Why?
|
| Electric Conductivity | 1 | 2011 | 94 | 0.100 |
Why?
|
| Inhalation | 1 | 2011 | 42 | 0.100 |
Why?
|
| Myocardial Contraction | 2 | 2011 | 291 | 0.100 |
Why?
|
| Early Detection of Cancer | 2 | 2022 | 1258 | 0.100 |
Why?
|
| Anthropometry | 1 | 2011 | 269 | 0.090 |
Why?
|
| Esophagus | 1 | 2014 | 553 | 0.090 |
Why?
|
| Radiation Protection | 1 | 2011 | 205 | 0.090 |
Why?
|
| Surface Properties | 1 | 2010 | 180 | 0.090 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2011 | 204 | 0.090 |
Why?
|
| Pattern Recognition, Automated | 2 | 2007 | 125 | 0.090 |
Why?
|
| Mesothelioma | 1 | 2015 | 544 | 0.090 |
Why?
|
| X-Rays | 3 | 2005 | 146 | 0.090 |
Why?
|
| Chemoradiotherapy | 1 | 2018 | 1946 | 0.080 |
Why?
|
| Coronary Vessels | 2 | 2011 | 665 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2015 | 732 | 0.080 |
Why?
|
| Likelihood Functions | 3 | 1998 | 233 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2017 | 12873 | 0.080 |
Why?
|
| Rest | 1 | 2008 | 71 | 0.080 |
Why?
|
| Prostheses and Implants | 2 | 2007 | 295 | 0.080 |
Why?
|
| Models, Structural | 2 | 1997 | 103 | 0.070 |
Why?
|
| Gated Blood-Pool Imaging | 2 | 2015 | 17 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 1866 | 0.070 |
Why?
|
| Exercise Test | 1 | 2008 | 312 | 0.070 |
Why?
|
| Models, Anatomic | 1 | 2007 | 154 | 0.070 |
Why?
|
| Information Storage and Retrieval | 1 | 2007 | 135 | 0.070 |
Why?
|
| Pulmonary Ventilation | 1 | 2006 | 45 | 0.070 |
Why?
|
| Hodgkin Disease | 1 | 2014 | 1429 | 0.060 |
Why?
|
| Gold | 1 | 2007 | 270 | 0.060 |
Why?
|
| Radiometry | 2 | 2008 | 980 | 0.060 |
Why?
|
| Lung Volume Measurements | 2 | 2015 | 88 | 0.060 |
Why?
|
| Normal Distribution | 2 | 2009 | 61 | 0.060 |
Why?
|
| Software | 2 | 2010 | 1321 | 0.060 |
Why?
|
| Barium Sulfate | 1 | 2003 | 40 | 0.060 |
Why?
|
| Observer Variation | 2 | 2016 | 671 | 0.060 |
Why?
|
| Electrocardiography | 3 | 2018 | 1145 | 0.060 |
Why?
|
| Models, Biological | 1 | 2012 | 3254 | 0.060 |
Why?
|
| Diaphragm | 1 | 2004 | 181 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 509 | 0.050 |
Why?
|
| Adult | 8 | 2018 | 77950 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 1374 | 0.050 |
Why?
|
| Dogs | 1 | 2004 | 1155 | 0.050 |
Why?
|
| Principal Component Analysis | 2 | 2013 | 218 | 0.050 |
Why?
|
| Prognosis | 3 | 2015 | 21713 | 0.050 |
Why?
|
| Rubidium Radioisotopes | 1 | 2020 | 6 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2011 | 4078 | 0.050 |
Why?
|
| Mathematics | 2 | 1997 | 136 | 0.050 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2020 | 71 | 0.040 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 1999 | 10 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 1011 | 0.040 |
Why?
|
| Adenine | 1 | 2022 | 631 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 14889 | 0.040 |
Why?
|
| Perfusion | 1 | 2020 | 293 | 0.040 |
Why?
|
| Diffusion | 1 | 1998 | 88 | 0.040 |
Why?
|
| Prostate | 1 | 2023 | 1088 | 0.040 |
Why?
|
| Diastole | 1 | 2018 | 187 | 0.040 |
Why?
|
| Animals | 3 | 2015 | 59536 | 0.040 |
Why?
|
| False Positive Reactions | 2 | 2007 | 355 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 1997 | 202 | 0.040 |
Why?
|
| Quality Control | 2 | 2011 | 457 | 0.040 |
Why?
|
| Piperidines | 1 | 2022 | 1035 | 0.040 |
Why?
|
| Liver | 2 | 1997 | 2961 | 0.040 |
Why?
|
| Technetium Compounds | 1 | 1996 | 12 | 0.040 |
Why?
|
| Sternum | 1 | 1997 | 100 | 0.040 |
Why?
|
| Ribs | 1 | 1997 | 91 | 0.030 |
Why?
|
| Mice | 2 | 2015 | 34495 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2012 | 5437 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 2008 | 573 | 0.030 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2015 | 9 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 2027 | 0.030 |
Why?
|
| Spine | 1 | 1997 | 293 | 0.030 |
Why?
|
| Radiation Equipment and Supplies | 1 | 2014 | 4 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2019 | 1021 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2015 | 181 | 0.030 |
Why?
|
| Polyethylene | 1 | 2014 | 19 | 0.030 |
Why?
|
| Radiography, Abdominal | 1 | 2015 | 120 | 0.030 |
Why?
|
| Computers | 1 | 2014 | 141 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 10035 | 0.030 |
Why?
|
| Organs at Risk | 1 | 2016 | 514 | 0.030 |
Why?
|
| Calibration | 1 | 2014 | 337 | 0.030 |
Why?
|
| Posture | 1 | 2014 | 215 | 0.030 |
Why?
|
| Lymphography | 1 | 2011 | 51 | 0.030 |
Why?
|
| Arabinofuranosyluracil | 1 | 2011 | 42 | 0.030 |
Why?
|
| Thymidine Kinase | 1 | 2011 | 193 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 2011 | 113 | 0.020 |
Why?
|
| Fiducial Markers | 1 | 2011 | 96 | 0.020 |
Why?
|
| Lymphatic Vessels | 1 | 2011 | 143 | 0.020 |
Why?
|
| Whole-Body Counting | 1 | 2009 | 27 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 5112 | 0.020 |
Why?
|
| Safety | 1 | 2011 | 465 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 612 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 798 | 0.020 |
Why?
|
| Electromyography | 1 | 2009 | 226 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 7789 | 0.020 |
Why?
|
| Photons | 2 | 2006 | 507 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 2803 | 0.020 |
Why?
|
| Swine | 1 | 2011 | 1541 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2000 | 2195 | 0.020 |
Why?
|
| Computer Systems | 1 | 2007 | 106 | 0.020 |
Why?
|
| Glucose-6-Phosphate | 1 | 2006 | 14 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 15694 | 0.020 |
Why?
|
| Hyperventilation | 1 | 2006 | 19 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2007 | 253 | 0.020 |
Why?
|
| Respiratory Muscles | 1 | 2006 | 27 | 0.020 |
Why?
|
| Subclavian Vein | 1 | 2006 | 35 | 0.020 |
Why?
|
| Pleurodesis | 1 | 2006 | 71 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2006 | 57 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 4892 | 0.020 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2008 | 334 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 1182 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2011 | 2231 | 0.020 |
Why?
|
| Metals | 1 | 2006 | 155 | 0.020 |
Why?
|
| Brain | 1 | 1999 | 4113 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2011 | 1048 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 4988 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 3045 | 0.020 |
Why?
|
| Uncertainty | 1 | 2007 | 320 | 0.020 |
Why?
|
| Precision Medicine | 1 | 2012 | 1154 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2004 | 112 | 0.020 |
Why?
|
| Water | 1 | 2006 | 361 | 0.020 |
Why?
|
| Biophysics | 1 | 2004 | 111 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2009 | 717 | 0.010 |
Why?
|
| Linear Models | 1 | 2007 | 1085 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 5114 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2012 | 1423 | 0.010 |
Why?
|
| Bile Duct Neoplasms | 1 | 2008 | 493 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 4744 | 0.010 |
Why?
|
| Cholangiocarcinoma | 1 | 2008 | 493 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2007 | 13658 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2011 | 2967 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 1544 | 0.010 |
Why?
|
| Aortography | 1 | 2000 | 181 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 3981 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 1390 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 2000 | 244 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 1270 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 7222 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 4844 | 0.010 |
Why?
|
| Technetium | 1 | 1997 | 77 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 1997 | 111 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1999 | 471 | 0.010 |
Why?
|
| Rectal Neoplasms | 1 | 2003 | 1202 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 21445 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 1997 | 603 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 31252 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 1996 | 671 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 15862 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 4849 | 0.010 |
Why?
|